Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/1993
09/21/1993US5246932 Adenosine antagonist such as vasodilation
09/21/1993US5246930 9-substituted compounds of 3α, 11α-epoxy-3,4,5,5aα,6,7,8,8a,9,11,11a-undecahydro-3β,6.alpha.,9-trimethylfurano[3,4-j][1,2]benzodioxepin, processes for their preparation and their use as antiprotozoal and antiviral agents
09/21/1993US5246929 Prophylaxis or treatment of ischemic encephalopathia
09/21/1993US5246926 Cephalosporin derivatives
09/21/1993US5246924 Method for treating hepatitis B virus infections using 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-ethyluracil
09/21/1993US5246922 Inotropic agents
09/21/1993US5246726 Iron-containing composition and method for treatment of cancer
09/21/1993US5246711 Dosage form for treating dysthymia
09/21/1993US5246710 Dosage form for treating cyclothymia
09/21/1993US5246709 Antiemetic therapy
09/21/1993US5246706 Laminated elastomer patch
09/21/1993US5246704 Vaginal suppository
09/21/1993US5246702 Process for the purification of commercial carrageenins
09/21/1993US5246697 Kanamycin A with vehicle or support
09/21/1993US5245896 Quick-change tool holder with center height adjustment mechanism
09/21/1993CA2091942A1 Pharmaceutical composition
09/21/1993CA2081280A1 Use of preparations containing chromium and vitamins e and c for controlling carbohydrate and lipid metabolism
09/21/1993CA1322374C Substituted di-t-butylphenols
09/21/1993CA1322372C Tetrahydrobenzothiazoles, and the preparation and use thereof
09/21/1993CA1322371C Carbapenem compound in crystalline form, and its production and use
09/21/1993CA1322370C Phosphate ester derivatives, their preparation and their therapeutic use
09/21/1993CA1322369C 2-(4-sulfur containing-benzylamino)-benzothiazole compounds
09/21/1993CA1322368C Fused heteroalkylene quinolinamines, a process and intermediates for their preparation and their use as medicaments
09/21/1993CA1322367C Thienotriazolodiazepine compounds and pharmaceutical uses thereof
09/21/1993CA1322334C2 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-piperazino- quinoline-3-carboxylic acid- containing compositions and uses thereof
09/21/1993CA1322328C Stabilized compositions containing epidermal growth factor
09/19/1993WO1993018764A2 VERAPAMIL HCl FORMULATION AND OTHER OPHTHALMIC SOLUTIONS WITH BUFFER SYSTEM FOR OCULAR ADMINISTRATION
09/19/1993WO1993018763A1 Compositions of n-(phosphonoacetyl)-l-aspartic acid and methods of their use as broad spectrum antivirals
09/19/1993CA2102110A1 Verapamil hci formulation and other ophthalmic solutions with buffer system for ocular administration
09/19/1993CA2091874A1 Triazolopyridazine compounds, their production and use
09/19/1993CA2091866A1 Agent for treatment of chronic fatigue syndrome
09/19/1993CA2091829A1 Cyclic aminomethylene bisphosphonate derivatives
09/19/1993CA2091828A1 Risk determination for drug treatment
09/19/1993CA2091715A1 Argatroban preparations for ophthalmic use
09/19/1993CA2091634A1 Enantiomer (-)-n-(2-ethoxyphenyl)-n'- (1,2,2-trimethylpropyl)-2-nitroethene-1-, 1-diamine, process for the preparation thereof and the use thereof
09/19/1993CA2091214A1 Pyrimidine derivatives
09/18/1993CA2091713A1 Dosage aerosols containing the active substance flezelastin and related structures
09/17/1993EP0609210A4 OPTICALLY ACTIVE 5H-PYRROLO 3,4-b]PYRAZINE DERIVATIVE, ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME.
09/17/1993EP0572635A4 Novel compounds having a guanidine structure and pharmaceutical composition containing same.
09/17/1993EP0571593A4 New non ionic iodized agents for x-ray contrasting, method for preparing them and galenical compositions containing them.
09/17/1993CA2092671A1 2-oxoquinoline derivatives
09/17/1993CA2091550A1 New derivatives of physostigmine, their use and pharmaceutical formulations containing them
09/16/1993WO1993018173A2 Cd4 binding agents and inhibitors of collagenase and protein kinase c
09/16/1993WO1993018172A1 Compounds for modulating growth of infectious agents
09/16/1993WO1993018143A1 Dna encoding taurine and gaba transporters and uses thereof
09/16/1993WO1993018057A1 4-oxo-2 thioxoimidazolidine derivates as inhibitors of blood platelet aggregation
09/16/1993WO1993018056A1 Isosteric antiherpes peptide derivatives
09/16/1993WO1993018053A1 METHOD FOR MAKING 3α-HYDROXY,3β-SUBSTITUTED-PREGNANES
09/16/1993WO1993018050A1 Sugar derivatives of macrolides
09/16/1993WO1993018049A1 Fluorosugar derivatives of macrolides
09/16/1993WO1993018048A1 2-aminosugar derivatives of macrolides
09/16/1993WO1993018044A1 Cephalosporin derivatives
09/16/1993WO1993018042A1 Desosamino derivatives of macrolides as immunosuppressants and antifungal agents
09/16/1993WO1993018040A1 Cyclic ketal derivatives
09/16/1993WO1993018039A1 Cyclic ketal derivatives
09/16/1993WO1993018037A1 Epibatidine and derivatives, compositions and methods of treating pain
09/16/1993WO1993018036A1 Condensed indole derivatives as 5ht4-receptor antagonists
09/16/1993WO1993018034A1 Process for the preparation of ergoline derivatives
09/16/1993WO1993018033A1 Biologically active tropane derivatives
09/16/1993WO1993018032A1 Indole derivatives as 5-ht1 agonists
09/16/1993WO1993018030A1 Benzimidazole derivatives as angiotensin ii antagonists
09/16/1993WO1993018029A1 Imidazole, triazole and tetrazole derivatives
09/16/1993WO1993018028A1 Indole derivatives as 5ht1c antagonists
09/16/1993WO1993018027A1 Nitrogen containing heterocyclic compounds useful as pharmaceuticals
09/16/1993WO1993018025A1 N,n'-disubstituted amide derivative
09/16/1993WO1993018024A1 1-alkoxy-2-(alkoxy- or cycloalkoxy)-4-(cyclo thioalkyl- or cyclothioalkenyl)benzenes as inhibitors of cyclic amp phosphodiesterase and tumour necrosis factor
09/16/1993WO1993018023A1 Heterocyclic compounds, processes for their preparation and pharmaceutical compositions containing them
09/16/1993WO1993018009A1 Antiviral nucleoside analogues
09/16/1993WO1993018006A1 Amine derivatives of oxo- and hydroxy-substitued hydrocarbons
09/16/1993WO1993018003A1 Substitued pipecolinic acid derivatives as hiv protease inhibitors
09/16/1993WO1993018002A1 Quaternary salts of 4-substituted piperidines, preparation thereof and pharmaceutical compositions containing same
09/16/1993WO1993017991A1 TETRALIN DERIVATIVES AS HMG-CoA REDUCTASE INHIBITORS
09/16/1993WO1993017746A1 Antibacterial coated medical implants
09/16/1993WO1993017717A1 Compositions and methods for modulating rna
09/16/1993WO1993017713A1 Pharmaceutical composition having site-specific delivery
09/16/1993WO1993017711A1 New cyclodextrins and new formulated drugs
09/16/1993WO1993017709A1 Antipruritic
09/16/1993WO1993017696A1 Method for kidney tubulogenesis
09/16/1993WO1993017695A1 Diagnosis and treatment of various neuralgias
09/16/1993WO1993017692A1 Dual action 2',5'-oligoadenylate antiviral derivatives and uses thereof
09/16/1993WO1993017691A2 Pharmaceutical compositions containing monosialoganglioside gm1 or a derivative thereof suitable for the treatment of parkinson's disease
09/16/1993WO1993017690A1 Halichondrins and related compounds
09/16/1993WO1993017689A1 Method for protection against genotoxic mutagenesis
09/16/1993WO1993017687A1 Topical compositions containing steroids
09/16/1993WO1993017686A1 Estrogen/progestin/antiprogestin method and kit for oral contraception and regulating menses
09/16/1993WO1993017685A1 Combinations of ace inhibitors and diuretics
09/16/1993WO1993017684A2 Enantiomeric hydroxylated xanthine compounds
09/16/1993WO1993017683A1 Application of 2-amino 6-trifluoromethoxy benzothiazole (riluzole) for obtaining a drug useful in the treatment of motor neuron diseases
09/16/1993WO1993017682A1 Angiotensin ii receptor antagonists
09/16/1993WO1993017680A1 Antipyretic and analgesic methods and compositions containing optically pure r-etodolac
09/16/1993WO1993017679A1 Compositions containing ranitidine/bismuth carboxylates salts
09/16/1993WO1993017677A1 Antipyretic and analgesic methods and compositions containing optically pure r(-) ketoprofen
09/16/1993WO1993017676A1 Antifungal agents
09/16/1993WO1993017675A1 Use of alkylureas and hydroxyurea as contraceptive agents
09/16/1993WO1993017674A1 Topical use of local anaesthetic agents for rheumatoid arthritis as well as a pharmaceutical preparation and a method for the treatment thereof
09/16/1993WO1993017673A1 Sustained release analgesics
09/16/1993WO1993017672A1 Treatment of migraine
09/16/1993WO1993017671A1 Treatment and prophylaxis of diseases caused by parasites, or bacteria
09/16/1993WO1993017670A1 Reducing post-prandial fluctuations in plasma concentrations of large neutral amino acids (lnaa)
09/16/1993WO1993017667A1 Composition for oral preparations